A novel disease gene for Brugada syndrome: sarcolemmal membrane-associated protein gene mutations impair intracellular trafficking of hNav1.5
- PMID: 23064965
- DOI: 10.1161/CIRCEP.111.969972
A novel disease gene for Brugada syndrome: sarcolemmal membrane-associated protein gene mutations impair intracellular trafficking of hNav1.5
Abstract
Background: Mutations in genes including SCN5A encoding the α-subunit of the cardiac sodium channel (hNav1.5) cause Brugada syndrome via altered function of cardiac ion channels, but more than two-thirds of Brugada syndrome remains pathogenetically elusive. T-tubules and sarcoplasmic reticulum are essential in excitation of cardiomyocytes, and sarcolemmal membrane-associated protein (SLMAP) is a protein of unknown function localizing at T-tubules and sarcoplasmic reticulum.
Methods and results: We analyzed 190 unrelated Brugada syndrome patients for mutations in SLMAP. Two missense mutations, Val269Ile and Glu710Ala, were found in heterozygous state in 2 patients but were not found in healthy individuals. Membrane surface expression of hNav1.5 in the transfected cells was affected by the mutations, and silencing of mutant SLMAP by small interfering RNA rescued the surface expression of hNav1.5. Whole-cell patch-clamp recordings of hNav1.5-expressing cells transfected with mutant SLMAP confirmed the reduced hNav1.5 current.
Conclusions: The mutations in SLMAP may cause Brugada syndrome via modulating the intracellular trafficking of hNav1.5 channel.
Similar articles
-
Loss of function associated with novel mutations of the SCN5A gene in patients with Brugada syndrome.Can J Cardiol. 2004 Mar 15;20(4):425-30. Can J Cardiol. 2004. PMID: 15057319
-
p.D1690N Nav1.5 rescues p.G1748D mutation gating defects in a compound heterozygous Brugada syndrome patient.Heart Rhythm. 2013 Feb;10(2):264-72. doi: 10.1016/j.hrthm.2012.10.025. Epub 2012 Oct 18. Heart Rhythm. 2013. PMID: 23085483
-
Electrophysiological and trafficking defects of the SCN5A T353I mutation in Brugada syndrome are rescued by alpha-allocryptopine.Eur J Pharmacol. 2015 Jan 5;746:333-43. doi: 10.1016/j.ejphar.2014.09.028. Epub 2014 Sep 23. Eur J Pharmacol. 2015. PMID: 25261036
-
[Genetic and molecular basis for sodium channel-mediated Brugada syndrome].Arch Cardiol Mex. 2013 Oct-Dec;83(4):295-302. doi: 10.1016/j.acmx.2013.10.001. Epub 2013 Nov 21. Arch Cardiol Mex. 2013. PMID: 24269159 Review. Spanish.
-
Clinical Spectrum of SCN5A Mutations: Long QT Syndrome, Brugada Syndrome, and Cardiomyopathy.JACC Clin Electrophysiol. 2018 May;4(5):569-579. doi: 10.1016/j.jacep.2018.03.006. Epub 2018 May 2. JACC Clin Electrophysiol. 2018. PMID: 29798782 Review.
Cited by
-
Deletion of Sarcolemmal Membrane-Associated Protein Isoform 3 (SLMAP3) in Cardiac Progenitors Delays Embryonic Growth of Myocardium without Affecting Hippo Pathway.Int J Mol Sci. 2024 Mar 1;25(5):2888. doi: 10.3390/ijms25052888. Int J Mol Sci. 2024. PMID: 38474134 Free PMC article.
-
A Contemporary Review of the Genomic Associations of Coronary Artery Myocardial Bridging.Genes (Basel). 2023 Dec 4;14(12):2175. doi: 10.3390/genes14122175. Genes (Basel). 2023. PMID: 38136997 Free PMC article. Review.
-
Brugada Syndrome: More than a Monogenic Channelopathy.Biomedicines. 2023 Aug 18;11(8):2297. doi: 10.3390/biomedicines11082297. Biomedicines. 2023. PMID: 37626795 Free PMC article. Review.
-
Genetic and Molecular Mechanisms in Brugada Syndrome.Cells. 2023 Jul 5;12(13):1791. doi: 10.3390/cells12131791. Cells. 2023. PMID: 37443825 Free PMC article. Review.
-
Glucagon-Like Peptide-1 Receptor Agonist Protects Against Diabetic Cardiomyopathy by Modulating microRNA-29b-3p/SLMAP.Drug Des Devel Ther. 2023 Mar 12;17:791-806. doi: 10.2147/DDDT.S400249. eCollection 2023. Drug Des Devel Ther. 2023. PMID: 36936522 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous
